Psychedelics Psilera raises US$8.8M to fight dementia with non-psychoactive psilocybin drug The biotech is preparing for in-human trials with 'PSIL-006' next year Rowan DunneMay 29, 2026
Psychedelics Enveric Biosciences skyrockets on patent allowance for psychedelic-inspired molecules Lead drug candidate EB-301 is structurally similar to DMT Rowan DunneDecember 11, 2025
Psychedelics Scientists coin the term ‘PiPi drugs’: a new frontier in psychedelic medicine Non-psychoactive therapeutics derived from psychedelic compounds have promising anti-inflammatory properties Rowan DunneSeptember 5, 2025
News Delix Therapeutics to start clinical trial on novel psychoplastogen drug DLX-001 is a non-hallucinogenic compound intended to treat various mental health conditions Rowan DunneMay 9, 2023